CalciMedica is trading at $0.50 (-14.89%) after announcing a one-for-five reverse stock split intended to restore compliance with Nasdaq’s minimum bid-price requirement.
- Announced August 27, 2026; effective after market close on August 28, with split-adjusted trading scheduled to begin August 31.
- Shares outstanding will decrease from approximately 34.5 million to 6.9 million.
- The compliance-driven action likely explains the decline despite broader indexes trading higher.